PHH2.F · Paul Hartmann AG

-

Please sign in to comment on PHH2.F

1 Comment

Admin

4 years ago

Paul Hartmann AG is currently in a long term downtrend where the price is trading 1.1% below its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.6.

Paul Hartmann AG's total revenue sank by 0.0% to $560M since the same quarter in the previous year.

Its net income has dropped by 0.0% to $12M since the same quarter in the previous year.

Finally, its free cash flow grew by 150.9% to $61M since the same quarter in the previous year.

Based on the above factors, Paul Hartmann AG gets an overall score of 2/5.

CurrencyCode	EUR
Exchange	F
Sector	Healthcare
Industry	Medical Instruments & Supplies
ISIN	DE0007474041

Target Price	None
Dividend Yield	3.4%
Beta	0.57
Market Cap	902M
PE Ratio	8.32

ABOUT

Paul Hartmann AG

Paul Hartmann AG manufactures and sells medical and care products in Germany, rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Incontinence Management, Wound Care, and Infection Management. It offers body-absorbent products and traditional and modern wound dressings. In addition, the company produce single-use products and solutions for infection; hand, surface, and instrument disinfection; and cleaning, skin care, and skin antisepsis. Further, it offers Link, a platform to learn and exchange medical and clinical knowledge. It sells its products through pharmacies, medical supply stores, and online channels. The company was founded in 1818 and is headquartered in Heidenheim, Germany.

PHH2.F · Paul Hartmann AG

-

Paul Hartmann AG

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Paul Hartmann AG using a moving average strategy